We serve Chemical Name:4-(2-oxo-2-phenylacetyl)benzoic acid CAS:72857-25-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(2-oxo-2-phenylacetyl)benzoic acid
CAS.NO:72857-25-1
Synonyms:Benzil-based compound,14;Benzil-carbonsaeure-(4);4-(2-Oxo-2-phenyl-acetyl)-benzoic acid;4-[oxo(phenyl)acetyl]benzoic acid
Molecular Formula:C15H10O4
Molecular Weight:254.23700
HS Code:2918300090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:469.3ºC at 760 mmHg
Density:1.317g/cm3
Index of Refraction:1.624
PSA:71.44000
Exact Mass:254.05800
LogP:2.45040
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzil-based compound,14 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[oxo(phenyl)acetyl]benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[oxo(phenyl)acetyl]benzoic acid Use and application,Benzil-carbonsaeure-(4) technical grade,usp/ep/jp grade.
Related News: TSA notified airlines Saturday about the restrictions. CNN is reaching out to TSA for comment. 4-(2-oxo-2-phenylacetyl)benzoic acid manufacturer TSA notified airlines Saturday about the restrictions. CNN is reaching out to TSA for comment. 4-(2-oxo-2-phenylacetyl)benzoic acid supplier TSA notified airlines Saturday about the restrictions. CNN is reaching out to TSA for comment. 4-(2-oxo-2-phenylacetyl)benzoic acid vendor Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. 4-(2-oxo-2-phenylacetyl)benzoic acid factory Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.
